PLXS Stock Analysis: Plexus | NASDAQ
Electronic Components | NASDAQ, USA | Market Cap: 7.361m USD | 12M Return: 99.3% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 89.4M
EPS Trend: 78.1%
Qual. Beats: 1
Rev. Trend: -8.9%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Plexus Corp. (PLXS) is a U.S.-headquartered provider of electronic manufacturing services (EMS), operating across the Americas, the Asia-Pacific region, Europe, the Middle East, and Africa. The company delivers end-to-end solutions-including design, supply chain management, new product introduction, manufacturing, and post-production sustaining services-to customers in the aerospace/defense, healthcare/life sciences, and industrial/commercial sectors. Founded in 1979 in Neenah, Wisconsin, and listed on the NASDAQ since 1986, Plexus operates as a mid-cap information technology company within the EMS sub-industry, a segment in which contract manufacturers produce electronic assemblies and finished goods on behalf of original equipment manufacturers (OEMs), allowing those customers to focus capital and resources on design, R&D, and branding.
- Healthcare and life sciences segment revenue accelerates on new program wins
- Aerospace and defense demand expands manufacturing backlog and revenue
- Gross margins compress on labor inflation and elevated supply chain costs
| Net Income: 187.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -9.14 > 1.0 |
| NWC/Revenue: 21.46% < 20% (prev 20.93%; Δ 0.53% < -1%) |
| CFO/TA 0.05 > 3% & CFO 172.0m > Net Income 187.5m |
| Net Debt (-17.4m) to EBITDA (297.0m): -0.06 < 3 |
| Current Ratio: 1.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.4m) vs 12m ago -1.06% < -2% |
| Gross Margin: 10.05% > 18% (prev 10.10%; Δ -0.05% > 0.5%) |
| Asset Turnover: 133.7% > 50% (prev 128.6%; Δ 5.14% > 0%) |
| Interest Coverage Ratio: 19.57 > 6 (EBIT TTM 219.6m / Interest Expense TTM 11.2m) |
| A: 0.28 (Total Current Assets 2.64b - Total Current Liabilities 1.71b) / Total Assets 3.36b |
| B: 0.62 (Retained Earnings 2.09b / Total Assets 3.36b) |
| C: 0.07 (EBIT TTM 219.6m / Avg Total Assets 3.22b) |
| D: 0.80 (Book Value of Equity 1.49b / Total Liabilities 1.87b) |
| Altman-Z'' = 5.12 = AAA |
| DSRI: 1.07 (Receivables 862.7m/745.6m, Revenue 4.31b/3.97b) |
| GMI: 1.00 (GM 10.10% / 10.05%) |
| AQI: 1.09 (AQ_t 0.04 / AQ_t-1 0.03) |
| SGI: 1.09 (Revenue 4.31b / 3.97b) |
| TATA: 0.00 (NI 187.5m - CFO 172.0m) / TA 3.36b) |
| Beneish M = -2.85 (Cap -4..+1) = A |
As of July 10, 2026, the stock is trading at USD 270.56 with a total of 326,195 shares traded. Over the past week, the price has changed by -6.76%, over one month by -3.88%, over three months by +21.13% and over the past year by +99.29%.
Current recommended Stop Loss: 253.00 (which is 6.5% or 1.2 ATR below the current price).
Plexus has received a consensus analysts rating of 3.80. Therefore, it is recommended to hold PLXS.
- StrongBuy: 1
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 293.3 | 8.4% |
P/E Trailing = 40.2796
P/E Forward = 30.303
P/S = 1.7078
P/B = 5.2153
P/EG = 2.0859
Revenue TTM = 4.31b USD
EBIT TTM = 219.6m USD
EBITDA TTM = 297.0m USD
Long Term Debt = 91.0m USD (from longTermDebt, last quarter)
Short Term Debt = 143.1m USD (from shortTermDebt, last quarter)
Debt = 285.7m USD (from shortLongTermDebtTotal, last quarter) + Leases 25.8m
Net Debt = -17.4m USD (calculated: Debt 285.7m - CCE 303.1m)
Enterprise Value = 7.34b USD (7.36b + Debt 285.7m - CCE 303.1m)
Interest Coverage Ratio = 19.57 (Ebit TTM 219.6m / Interest Expense TTM 11.2m)
EV/FCF = 96.89x (Enterprise Value 7.34b / FCF TTM 75.8m)
FCF Yield = 1.03% (FCF TTM 75.8m / Enterprise Value 7.34b)
FCF Margin = 1.76% (FCF TTM 75.8m / Revenue TTM 4.31b)
Net Margin = 4.35% (Net Income TTM 187.5m / Revenue TTM 4.31b)
Gross Margin = 10.05% ((Revenue TTM 4.31b - Cost of Revenue TTM 3.88b) / Revenue TTM)
Gross Margin QoQ = 10.24% (prev 9.92%)
Tobins Q-Ratio = 2.18 (Enterprise Value 7.34b / Total Assets 3.36b)
Interest Expense / Debt = 3.93% (Interest Expense 11.2m / Debt 285.7m)
Taxrate = 10.02% (20.9m / 208.4m)
NOPAT = 197.6m (EBIT 219.6m * (1 - 10.02%))
Current Ratio = 1.54 (Total Current Assets 2.64b / Total Current Liabilities 1.71b)
Debt / Equity = 0.19 (Debt 285.7m / totalStockholderEquity, last quarter 1.49b)
Debt / EBITDA = -0.06 (Net Debt -17.4m / EBITDA 297.0m)
Debt / FCF = -0.23 (Net Debt -17.4m / FCF TTM 75.8m)
Total Stockholder Equity = 1.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.82% (Net Income 187.5m / Total Assets 3.36b)
RoE = 12.83% (Net Income TTM 187.5m / Total Stockholder Equity 1.46b)
RoCE = 14.15% (EBIT 219.6m / Capital Employed (Equity 1.46b + L.T.Debt 91.0m))
RoIC = 12.54% (NOPAT 197.6m / Invested Capital 1.58b)
WACC = 9.99% (E(7.36b)/V(7.65b) * Re(10.24%) + D(285.7m)/V(7.65b) * Rd(3.93%) * (1-Tc(0.10)))
Discount Rate = 10.24% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -59.63 | Cagr: -1.60%
[DCF] Terminal Value 67.22% ; FCFF base≈186.1m ; Y1≈163.2m ; Y5≈131.9m
[DCF] Fair Price = 62.99 (EV 1.67b - Net Debt -17.4m = Equity 1.69b / Shares 26.8m; r=9.99% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 78.08 | EPS CAGR: 16.49% | SUE: 1.58 | # QB: 1
Revenue Correlation: -8.93 | Revenue CAGR: -0.32% | SUE: 1.77 | # QB: 1
EPS current Quarter (2026-06-30): EPS=2.14 | Chg30d=+0.19% | Revisions=+25% | Analysts=5
EPS current Year (2026-09-30): EPS=8.23 | Chg30d=+0.19% | Revisions=+25% | GrowthEPS=+10.7% | GrowthRev=+17.2%
EPS next Year (2027-09-30): EPS=9.47 | Chg30d=+0.55% | Revisions=+40% | GrowthEPS=+15.1% | GrowthRev=+10.9%
[Analyst] Revisions Ratio: +57% (up=4, down=0)